New Insights in the Management of Antipsychotics in the Treatment of Schizophrenia in a Patient with Prolactinoma: A Case Report and Review of the Literature

New Insights in the Management of Antipsychotics in the Treatment of Schizophrenia in a Patient with Prolactinoma: A Case Report and Review of the Literature

Prolactinomas are the commonest pituitary adenomas and the major pathological cause of hyperprolactinaemia. Symptomatic prolactinomas are treated mainly by dopamine agonists; surgery and radiotherapy are options for nonresponders. Schizophrenia treatment is based on antipsychotics, which acts mainl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elvis Henrique Santos Andrade, Pedro Mario Pan, Paula F. Ramalho da Silva, Ary Gadelha
Format:	Article
Language:	English
Published:	Wiley 2010-01-01
Series:	Case Reports in Medicine
Online Access:	http://dx.doi.org/10.1155/2010/573252
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Augmentation of Antipsychotic Medications with Low-Dose Clozapine in Treatment-Resistant Schizophrenia—Case Reports and Discussion
by: Zoe Harrison, et al.
Published: (2021-01-01)

Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report
by: Xiaobo Xie, et al.
Published: (2025-01-01)

Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular Antipsychotics
by: Nasratullah Wahidi, et al.
Published: (2016-01-01)

Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
by: Madhav P. Bhatta, et al.
Published: (2021-05-01)

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
by: Amanda M. Farr, et al.
Published: (2014-10-01)

Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials
by: Stefano Marini, et al.
Published: (2016-01-01)

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01)

Giant prolactinoma with progressive cranial settling and central herniation: a case report
by: Taha Shahbazi, et al.
Published: (2024-12-01)

Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)

Correction: Giant prolactinoma with progressive cranial settling and central herniation: a case report
by: Taha Shahbazi, et al.
Published: (2025-01-01)

Insights into audio-visual temporal perception in bipolar disorder and schizophrenia
by: Monica Gori, et al.
Published: (2025-01-01)

Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia
by: Frank Röhricht, et al.
Published: (2012-01-01)

Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders
by: Bole Cvetka Bačar, et al.
Published: (2017-03-01)

Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
by: I. Ratke, et al.
Published: (2025-03-01)

Machine learning-based prediction of antipsychotic efficacy from brain gray matter structure in drug-naive first-episode schizophrenia
by: Xiaodong Guo, et al.
Published: (2025-02-01)

Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
by: Chandrika Jayakanthi Subasinghe, et al.
Published: (2018-01-01)

Prolactinoma: A Massive Effect on Bone Mineral Density in a Young Patient
by: Scott Sperling, et al.
Published: (2016-01-01)

Treatment of tardive dyskinesia caused by long-term antipsychotic use: case reports and literature review
by: I. Pabarčiūtė, et al.
Published: (2020-12-01)

Are atypical antipsychotic medications better than the conventional ones?
by: Pedro Miguel Milián Vázquez., et al.
Published: (2005-04-01)

Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup
by: Ze Rui Wu, et al.
Published: (2016-01-01)

A rare case of double pituitary prolactinomas: the diagnostic application of intraoperative ultrasonography and DNA methylation markers
by: Jared C. Reese, et al.
Published: (2025-01-01)

Constrictive Pericarditis Associated with Atypical Antipsychotics
by: Kuan-chin Jean Chen, et al.
Published: (2012-01-01)

Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)

Schizophasia and Cognitive Impairment in Schizophrenia: A Literature Review
by: Sylwia Niedźwiadek, et al.
Published: (2024-12-01)

Antipsychotic prescribing practices and patient, family member and healthcare professional perceptions of antipsychotic prescribing in acute care settings: a scoping review protocol
by: Zahinoor Ismail, et al.
Published: (2022-06-01)

Sheehan Syndrome Presenting with Psychotic Manifestations Mimicking Schizophrenia in a Young Female: A Case Report and Review of the Literature
by: Nipun Lakshitha de Silva, et al.
Published: (2020-01-01)

Effect of Atypical Antipsychotic Usage at Therapeutic Doses on Daytime Sleepiness
by: Birol Topcu, et al.
Published: (2023-09-01)

Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics
by: S. Al-Aojan, et al.
Published: (2018-01-01)

Acute Necrotizing Pancreatitis following Long-Term Antipsychotic Use
by: David T. Liebers, et al.
Published: (2021-01-01)

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
by: Christian Frois, et al.
Published: (2013-05-01)

Antipsychotic-induced hyperprolactinemia: Toxicologic mechanism and the increased breast cancer risk
by: Steven B. Bird
Published: (2025-06-01)

Probing Cortical Sites of Antipsychotic Drug Action with in vivo Receptor Imaging
by: P. Shaw, et al.
Published: (2000-01-01)

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect
by: Igne Sinkeviciute, et al.
Published: (2012-01-01)

The Role of Leptin in Antipsychotic-Induced Weight Gain: Genetic and Non-Genetic Factors
by: Fabio Panariello, et al.
Published: (2012-01-01)

The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review
by: Rasha Alkholy, et al.
Published: (2025-01-01)

The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review
by: Catthoor Kirsten, et al.

The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review.
by: Rasha Alkholy, et al.
Published: (2025-01-01)

Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa: A systematic scoping review.
by: Solène Thorey, et al.
Published: (2023-01-01)

Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study
by: Karin Kallen, et al.
Published: (2022-06-01)

Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01)